| Aug 19 |
RedHill shares climb on results indicating potential use of opaganib for obesity-related disorders
|
| Aug 19 |
Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested
|
| Aug 19 |
RedHill Announces Positive Obesity and Diabetes Results with Opaganib
|
| Aug 16 |
RedHill Biopharma plans to implement ADS ratio change
|
| Aug 16 |
RedHill Biopharma Announces Plan to Implement ADS Ratio Change
|
| Aug 1 |
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
|
| Aug 1 |
Newly Published Positive Phase 3 Data Demonstrates 64% Increased Efficacy with RedHill's RHB-104 in Crohn's Disease
|
| Jul 22 |
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien
|
| Jul 9 |
RedHill terminates license agreement with Cosmo Technologies
|
| Jul 9 |
RedHill Biopharma Terminates License Agreement for Aemcolo®
|
